At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Abdominal wall reconstructionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Complex Abdominal Wall Reconstruction With Polyvinylidene (PVDF) Mesh in the Setting of Active Infection: a Prospective Case-control Series.
In Brief
A clinical study evaluating Abdominal wall reconstruction for Abdominal Wall Defect and 4 related conditions. Completed, enrolled 76 participants across 1 site.
Detailed Summary
The use of synthetic mesh to repair infected defects of the abdominal wall remains controversial. This study aimed to evaluate the short-term outcomes of using PVDF mesh to treat infected abdominal wall defects in the elective setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Wall Defect, Abdominal Wall Hernia, Abdominal Wall Infection, Abdominal Wall Fistula, Infection
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
Primary CompletionJan 2021
Study CompletionSep 2021
First PostedSep 2021
TodayJul 2026
First PostedSep 29, 2021
Enrollment StartMay 1, 2016
Primary CompletionJan 1, 2021
Study CompletionSep 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 4.8 years ago
Interventions
Abdominal wall reconstructionprocedure
The repair of abdominal wall defects with polyvinylidene (PVDF) mesh